A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia
Plk inhibitor, Phase I/II trial, acute myeloid leukaemia, non-intensive
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 August 2013
|
| In: |
British journal of haematology
Year: 2013, Jahrgang: 163, Heft: 2, Pages: 214-222 |
| ISSN: | 1365-2141 |
| DOI: | 10.1111/bjh.12518 |
| Online-Zugang: | Resolving-System, Volltext: http://doi.org/10.1111/bjh.12518 Verlag, Volltext: http://onlinelibrary.wiley.com/doi/10.1111/bjh.12518/full 
|
| Verfasserangaben: | Carsten Müller-Tidow, Gesine Bug, Michael Lübbert, Alwin Krämer, Jürgen Krauter, Peter Valent, David Nachbaur, Wolfgang E. Berdel, Oliver G. Ottmann, Holger Fritsch, Gerd Munzert, Pilar Garin-Chesa, Frank Fleischer, Tillmann Taube, Hartmut Döhner |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 856605522 | ||
| 003 | DE-627 | ||
| 005 | 20220810035348.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160411s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjh.12518 |2 doi | |
| 035 | |a (DE-627)856605522 | ||
| 035 | |a (DE-576)9856605520 | ||
| 035 | |a (DE-599)GBV856605522 | ||
| 035 | |a (OCoLC)1340145397 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 245 | 1 | 2 | |a A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia |c Carsten Müller-Tidow, Gesine Bug, Michael Lübbert, Alwin Krämer, Jürgen Krauter, Peter Valent, David Nachbaur, Wolfgang E. Berdel, Oliver G. Ottmann, Holger Fritsch, Gerd Munzert, Pilar Garin-Chesa, Frank Fleischer, Tillmann Taube, Hartmut Döhner |
| 264 | 1 | |c 16 August 2013 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Plk inhibitor, Phase I/II trial, acute myeloid leukaemia, non-intensive | ||
| 700 | 1 | |a Bug, Gesine |e VerfasserIn |0 (DE-588)1055034617 |0 (DE-627)792579704 |0 (DE-576)411120158 |4 aut | |
| 700 | 1 | |a Lübbert, Michael |e VerfasserIn |0 (DE-588)1054105367 |0 (DE-627)79104047X |0 (DE-576)409999768 |4 aut | |
| 700 | 1 | |a Krämer, Alwin |e VerfasserIn |0 (DE-588)1067780025 |0 (DE-627)819183431 |0 (DE-576)426900820 |4 aut | |
| 700 | 1 | |a Krauter, Jürgen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Valent, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nachbaur, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berdel, Wolfgang E. |d 1952- |e VerfasserIn |0 (DE-588)109371682 |0 (DE-627)501107002 |0 (DE-576)289640857 |4 aut | |
| 700 | 1 | |a Ottmann, Oliver G. |e VerfasserIn |0 (DE-588)1073558401 |0 (DE-627)829169059 |0 (DE-576)435167081 |4 aut | |
| 700 | 1 | |a Fritsch, Holger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Munzert, Gerd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Garin-Chesa, Pilar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fleischer, Frank |d 1986- |e VerfasserIn |0 (DE-588)1058510339 |0 (DE-627)797034455 |0 (DE-576)414691652 |4 aut | |
| 700 | 1 | |a Taube, Tillmann |d 1967- |e VerfasserIn |0 (DE-588)120613735 |0 (DE-627)70487377X |0 (DE-576)180451316 |4 aut | |
| 700 | 1 | |a Döhner, Hartmut |d 1957- |e VerfasserIn |0 (DE-588)110666585 |0 (DE-627)729880842 |0 (DE-576)375358846 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d Oxford [u.a.] : Wiley-Blackwell, 1955 |g 163(2013), 2, Seite 214-222 |h Online-Ressource |w (DE-627)269758941 |w (DE-600)1475751-5 |w (DE-576)09113997X |x 1365-2141 |7 nnas |a A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia |
| 773 | 1 | 8 | |g volume:163 |g year:2013 |g number:2 |g pages:214-222 |g extent:9 |a A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia |
| 856 | 4 | 0 | |u http://doi.org/10.1111/bjh.12518 |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com/doi/10.1111/bjh.12518/full |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210705 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1067780025 |a Krämer, Alwin |m 1067780025:Krämer, Alwin |d 50000 |e 50000PK1067780025 |k 0/50000/ |p 4 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 950000 |d 950950 |e 910000PM1015101798 |e 950000PM1015101798 |e 950950PM1015101798 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950950/ |p 1 |x j | ||
| 999 | |a KXP-PPN856605522 |e 3944868307 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Carsten","display":"Müller-Tidow, Carsten","family":"Müller-Tidow","role":"aut"},{"role":"aut","display":"Bug, Gesine","family":"Bug","given":"Gesine"},{"role":"aut","family":"Lübbert","display":"Lübbert, Michael","given":"Michael"},{"display":"Krämer, Alwin","family":"Krämer","given":"Alwin","role":"aut"},{"given":"Jürgen","display":"Krauter, Jürgen","family":"Krauter","role":"aut"},{"role":"aut","family":"Valent","display":"Valent, Peter","given":"Peter"},{"role":"aut","given":"David","display":"Nachbaur, David","family":"Nachbaur"},{"role":"aut","display":"Berdel, Wolfgang E.","family":"Berdel","given":"Wolfgang E."},{"given":"Oliver G.","family":"Ottmann","display":"Ottmann, Oliver G.","role":"aut"},{"given":"Holger","family":"Fritsch","display":"Fritsch, Holger","role":"aut"},{"role":"aut","display":"Munzert, Gerd","family":"Munzert","given":"Gerd"},{"family":"Garin-Chesa","display":"Garin-Chesa, Pilar","given":"Pilar","role":"aut"},{"role":"aut","given":"Frank","display":"Fleischer, Frank","family":"Fleischer"},{"family":"Taube","display":"Taube, Tillmann","given":"Tillmann","role":"aut"},{"role":"aut","given":"Hartmut","display":"Döhner, Hartmut","family":"Döhner"}],"origin":[{"dateIssuedDisp":"16 August 2013","dateIssuedKey":"2013"}],"name":{"displayForm":["Carsten Müller-Tidow, Gesine Bug, Michael Lübbert, Alwin Krämer, Jürgen Krauter, Peter Valent, David Nachbaur, Wolfgang E. Berdel, Oliver G. Ottmann, Holger Fritsch, Gerd Munzert, Pilar Garin-Chesa, Frank Fleischer, Tillmann Taube, Hartmut Döhner"]},"physDesc":[{"extent":"9 S."}],"language":["eng"],"recId":"856605522","relHost":[{"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"recId":"269758941","language":["eng"],"note":["Gesehen am 08.05.08"],"id":{"eki":["269758941"],"doi":["10.1111/(ISSN)1365-2141"],"zdb":["1475751-5"],"issn":["1365-2141"]},"origin":[{"publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedKey":"1955","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]","dateIssuedDisp":"1955-"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"corporate":[{"role":"isb","display":"British Society for Haematology"},{"display":"European Hematology Association","role":"isb"}],"title":[{"title":"British journal of haematology","title_sort":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology"}],"pubHistory":["1.1955 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"2","extent":"9","year":"2013","text":"163(2013), 2, Seite 214-222","volume":"163","pages":"214-222"},"disp":"A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemiaBritish journal of haematology"}],"title":[{"title_sort":"randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia","title":"A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia"}],"id":{"doi":["10.1111/bjh.12518"],"eki":["856605522"]},"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a MUELLERTIDRANDOMIZED1620 | ||